Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2008Frontiers in bioscienceOpen Access

Smad7 as a therapeutic agent for chronic kidney diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

HLHui Y. Lan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hui Y. Lan (2008) studied this question.

synapsesocial.com/papers/6a8a5fdb238a34ecf47227a1https://doi.org/10.2741/3057
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Balance Between CD45RChigh and CD45RClow CD4 T Cells in Rats Is Intrinsic to Bone Marrow-Derived Cells and Is Genetically Controlled2001 · 41 citations
  2. 2Blockade of the Effects of TGF-β1 on Mesangial Cells by Overexpression of Smad72002 · 44 citations
  3. 3Downregulation of Smad Transcriptional Corepressors SnoN and Ski in the Fibrotic Kidney2003 · 87 citations
  4. 4Transforming growth factor‐β and Smad signalling in kidney diseases2005 · 346 citations
  5. 5Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model2003 · 341 citations